Delivery Order SPE2DB22D1002-SPE2DB25FKUW8
Award Date
11/26/24
Potential Completion Date
11/27/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Ozempic, a diabetes medication, valued at $15,301.23. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 28, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of the pharmaceutical product Ozempic, a diabetes medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that the company holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award is for the delivery of Ozempic, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $6,487.57, has a completion date of December 14, 2023 and is a firm fixed-price delivery order. This award is part of a larger...
This federal contract award is for the pharmaceutical product Ozempic, a treatment used for diabetes management. The contract, valued at $20,077.82, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
The federal contract award is for the delivery of Ozempic, a medication used for the treatment of diabetes, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,797.57 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2022. The contract has an ultimate completion date of January 3, 2023 and is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Ozempic, a diabetes medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $70,358.64 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024, with a completion date of August 19, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,278.48 firm fixed-price delivery order is for the specialty medication Ozempic, a diabetes treatment, and has an ultimate completion date of October 9, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $14,581.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic, a diabetes medication, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ozempic, a pharmaceutical product used for diabetes management, with a ceiling value of $1,741.62 and a completion date of June 28, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the procurement of Ozempic, a medication used to treat diabetes, with a ceiling value of $10,074.09. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 21, 2024. The contract does not have a set-aside designation, indicating open competition. This...